Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice...
- Awards Mr. Saik an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) - NEW HAVEN, Conn...
– Preclinical data for ARV-393 presented at the European Hematology Association 2024 Annual Congress showed...
NEW HAVEN, Conn., June 17, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage...
NEW HAVEN, Conn., June 03, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage...
NEW HAVEN, Conn., May 23, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) today announced that two...
– After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.